U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07881926) titled 'Evaluation of MD60002 Device for Facial Skin Aging' on Oct. 13.
Brief Summary: This single-center, non-controlled, single-arm clinical study is designed to evaluate the performance and safety of the Class III investigational device MD60002 (composed of highly purified polynucleotides at 3%) for aesthetic use in the treatment of skin imperfections and wrinkles caused by physiological facial aging.
A total of 43 adult subjects presenting with facial wrinkles (Lemperle Wrinkle Severity Scale score >= 1) will be enrolled. Participants will receive intradermal injections of MD60002 according to a standardized protocol.
The primary endp...